BSX Q3 2019 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.7B+13.1% YoY

Gross Profit

$1.7B63.9% margin

Operating Income

$397M14.7% margin

Net Income

$126M4.7% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$502M

Free Cash Flow

$359M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$26.8B

Total Liabilities

$17.1B

Stockholders' Equity

$9.7B

Cash & Equivalents

$277M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.7B	$2.4B	+13.1%
Gross Profit	$1.7B	$1.6B	+9.1%
Operating Income	$397M	$411M	-3.4%
Net Income	$126M	$432M	-70.8%

Revenue Segments

Cardiovascular

$1.0B54%

MedSurg

$845M46%

Geographic Segments

UNITED STATES

$1.6B81%

Non-US

$373M19%